das Neves, Gustavo Machado <br/><br/>
Targeting pteridine reductase 1 and dihydrofolate reductase: the old is a new trend for leishmaniasis drug discovery.  [electronic resource] 

 -  Future medicinal chemistry  08 2019 
 - 2107-2130 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1756-8927 
<br/><br/><label>Standard No.: </label>10.4155/fmc-2018-0512  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antiprotozoal Agents--chemistry<br/>Drug Discovery<br/>Folic Acid Antagonists--chemistry<br/>Humans<br/>Leishmania--drug effects<br/>Leishmaniasis--drug therapy<br/>Molecular Targeted Therapy<br/>Multienzyme Complexes--antagonists & inhibitors<br/>Oxidoreductases--antagonists & inhibitors<br/>Tetrahydrofolate Dehydrogenase--metabolism<br/>Thymidylate Synthase--antagonists & inhibitors